A Cu()-based Fenton-like agent inducing mitochondrial damage for photo-assisted enhanced chemodynamic therapy

Increasing the reactive oxygen species (ROS) content at the tumor site is one of the effective strategies to promote intracellular oxidative stress and improve therapeutic efficiency. Herein, an atomically precise cinnamaldehyde-derived metal-organic Cu( i ) complex (denoted as DC-OD-Cu ) was ration...

Full description

Saved in:
Bibliographic Details
Published inDalton transactions : an international journal of inorganic chemistry Vol. 52; no. 18; pp. 6187 - 6193
Main Authors Hong, Zhaoguo, Zhong, Jingjing, Ding, Dangdang, Gong, Sihui, Zhang, Liangliang, Zhao, Shulin, Shen, Xing-Can, Liang, Hong, Huang, Fu-Ping
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 09.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Increasing the reactive oxygen species (ROS) content at the tumor site is one of the effective strategies to promote intracellular oxidative stress and improve therapeutic efficiency. Herein, an atomically precise cinnamaldehyde-derived metal-organic Cu( i ) complex (denoted as DC-OD-Cu ) was rationally constructed. DC-OD-Cu could preferentially accumulate in the mitochondria of HeLa cells due to the mitochondria-targeting ability of triphenylphosphine, which was accompanied by the generation of large amounts of highly toxic hydroxyl radicals (&z.rad;OH) via Cu( i )-mediated Fenton-like reactions. Meanwhile, greater ROS generation jointly results in mitochondrial damage under white LED light irradiation. Furthermore, the in vitro and in vivo results suggested that DC-OD-Cu possesses favorable cytotoxicity and inhibits tumor growth. We believe that this research might provide a controllable strategy to construct multifunctional metal organic complexes for ROS-involved CDT. A novel atomically precise Fenton-like agent ( DC-OD-Cu ) was rationally engineered for maximized ROS-amplified mitochondrial damage-mediated tumor therapy by synchronous chemodynamic/photodynamic therapy.
Bibliography:Electronic supplementary information (ESI) available. CCDC
For ESI and crystallographic data in CIF or other electronic format see DOI
https://doi.org/10.1039/d3dt00317e
2191945
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1477-9226
1477-9234
DOI:10.1039/d3dt00317e